Common Stock, Shares, Outstanding of BeOne Medicines Ltd. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BeOne Medicines Ltd. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • BeOne Medicines Ltd. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,441,075,618, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BeOne Medicines Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,441,075,618 +53,707,914 +3.9% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 1,438,083,590 +52,049,270 +3.8% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 1,428,203,304 +49,101,403 +3.6% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 1,403,281,823 +43,757,454 +3.2% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 1,387,367,704 +27,854,480 +2% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 1,386,034,320 +33,036,696 +2.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 1,379,101,901 +2,850,565 +0.21% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 1,359,524,369 -3,127,732 -0.23% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 1,359,513,224 +3,373,044 +0.25% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 1,352,997,624 +3,357,444 +0.25% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,376,251,336 +26,611,897 +2% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 1,362,652,101 +27,846,832 +2.1% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 1,356,140,180 +21,335,899 +1.6% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 1,349,640,180 +136,405,979 +11% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 1,349,639,439 +145,072,416 +12% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 1,334,805,269 +137,482,652 +11% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 1,334,804,281 +143,982,340 +12% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 1,213,234,201 +30,317,542 +2.6% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 1,204,567,023 +189,590,331 +19% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 1,197,322,617 +189,345,801 +19% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 1,190,821,941 +389,481,243 +49% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 1,182,916,659 +1,104,475,961 +1408% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 1,014,976,692 +230,537,060 +29% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 1,007,976,816 +230,563,632 +30% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 801,340,698 +25,077,514 +3.2% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 78,440,698 -692,622,486 -90% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 784,439,632 +82,876,448 +12% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 777,413,184 +78,470,454 +11% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 776,263,184 +184,190,854 +31% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 771,063,184 +181,290,854 +31% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 701,563,184 +182,660,835 +35% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 698,942,730 +180,340,381 +35% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 592,072,330 +76,238,721 +15% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 589,772,330 +161,253,299 +38% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 518,902,349 +90,983,318 +21% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 518,602,349 +91,158,418 +21% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 515,833,609 +399,659,515 +344% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 428,519,031 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 427,919,031 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 427,443,931 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 116,174,094 31 Dec 2015 10-K 22 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.